UPDATE: RBC Capital Maintains Pliant Therapeutics (PLRX) at Outperform (correction)
Tweet Send to a Friend
(Updated - March 1, 2022 4:42 AM EST)
RBC Capital analyst Brian Abrahams maintains Pliant Therapeutics (NASDAQ: PLRX) with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
RBC Capital analyst Brian Abrahams maintains Pliant Therapeutics (NASDAQ: PLRX) with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
